Qualcomm was known to be the leading system on chips (SOC) supplier of the leading smartphone manufacturers in China. In fact, in 2020, around 307 million chips were delivered to Chinese companies, but in a new report, it was stated by a research company that Qualcomm’s shipments have decreased by 48.1% year-on-year.
Qualcomm’s business at risk over its declining market share
As per CNBC, CINNO Research claimed that Qualcomm’s falling market share was because of the sanctions issued by the Trump administration against Huawei, the leading smartphone maker in China. The sanction also extends to other Chinese companies, including Xiaomi, Vivo, and Oppo, so Qualcomm lost millions of orders.
American companies are still prohibited from doing business with Chinese companies, so Qualcomm was left with no choice but to cut business with its big clients, including Huawei. Telcos in China were placed on the U.S. blacklist, which means American firms are banned from dealing with the names on the list.
The sanction imposed on Huawei and other Chinese tech firms proved to be a big blow to Qualcomm since its export plummet and ultimately hurting the business in the process. Its market share in China nosedived to 25.4% in 2020 against 2019’s 37.9%.
Rival chipmaker companies are taking over the biz
Now that it is impossible for Qualcomm to export its chips to China, local phone manufacturers, including Huawei, are looking for options, and they are now turning to MediaTek, a Taiwanese semiconductor company.
As a result, MediaTek is now emerging as the no. 1 chip supplier for major tech firms. It has really benefited from the US sanctions as it started to fill up the demand for chips, a major component of smartphones.
“As far as we know, OPPO, Vivo and Xiaomi and Huawei, the MediaTek share has increased a lot,” CINNO Research relayed to CNBC. “This is not only because of the excellent performance of MediaTek’s mid-end platform, but also it is undeniable that the U.S. has imposed a series of sanctions on Huawei & Hisilicon, forcing major manufacturers to seek more diversified, stable and reliable sources of supply."


SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Oil Prices Slip as U.S.-Iran Talks Ease Middle East Tensions
India–U.S. Interim Trade Pact Cuts Auto Tariffs but Leaves Tesla Out
Asian Markets Surge as Japan Election, Fed Rate Cut Bets, and Tech Rally Lift Global Sentiment
Dollar Near Two-Week High as Stock Rout, AI Concerns and Global Events Drive Market Volatility
South Africa Eyes ECB Repo Lines as Inflation Eases and Rate Cuts Loom
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
U.S. Stock Futures Slide as Tech Rout Deepens on Amazon Capex Shock
Australian Household Spending Dips in December as RBA Tightens Policy
Gold and Silver Prices Climb in Asian Trade as Markets Eye Key U.S. Economic Data
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Trump’s Inflation Claims Clash With Voters’ Cost-of-Living Reality
Japanese Pharmaceutical Stocks Slide as TrumpRx.gov Launch Sparks Market Concerns
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Japan Economy Poised for Q4 2025 Growth as Investment and Consumption Hold Firm
U.S. Stock Futures Rise as Markets Brace for Jobs and Inflation Data 



